Otsuka (OTCMKTS:OTSKY – Get Free Report) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 2.119-2.119 for the period, compared to the consensus EPS estimate of 1.980. The company issued revenue guidance of $17.1 billion-$17.1 billion, compared to the consensus revenue estimate of $16.7 billion.
Otsuka Stock Performance
Shares of Otsuka stock traded down $1.42 during trading on Friday, hitting $34.41. 50,665 shares of the company’s stock were exchanged, compared to its average volume of 37,305. The stock has a market capitalization of $36.96 billion and a price-to-earnings ratio of 14.52. The business has a 50-day simple moving average of $34.15 and a 200-day simple moving average of $33.52. Otsuka has a 52-week low of $23.67 and a 52-week high of $37.52. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.
Otsuka (OTCMKTS:OTSKY – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.19. The company had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, research analysts forecast that Otsuka will post 1.96 EPS for the current year.
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Read More
- Five stocks we like better than Otsuka
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
